DOJ: 'There Is No Executed Settlement' With Mylan On EpiPen Rebates; Grassley Seeks Details

By John Wilkerson / October 11, 2016 at 8:49 PM
Sen. Chuck Grassley (R-IA) is demanding more information about the unreleased $465 million settlement between the Justice Department and Mylan over EpiPen Medicaid rebates. The Senate Judiciary chair wants to know how much states are supposed to receive from Mylan's reported settlement, and he wants to know when and how CMS warned Mylan that it misclassified EpiPen as a generic. There are gaping holes in information about CMS' notification to Mylan on the EpiPen misclassification and about Mylan's settlement with...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.